# ğŸ§¬ AI-Driven Drug Discovery Pipeline

## Overview
This project demonstrates an end-to-end machine learning pipeline for drug target prediction. It integrates on-premises screening, cloud-based feature engineering, and Agentic AI to automate the identification of potential biotech targets.

## ğŸ— Architecture
The system operates on a hybrid cloud architecture:
1.  **Ingestion:** Raw molecular data is processed locally.
2.  **Engineering (Databricks):** Distributed PySpark clusters handle feature extraction (RDKit) and Silver/Gold Delta tables.
3.  **Training (AWS SageMaker):** Hyperparameter tuning jobs identify the optimal binding affinity model.
4.  **Inference (AWS Lambda & Bedrock):** An Event-driven architecture triggers predictions, and a Generative AI Agent allows natural language queries of the results.

## ğŸ›  Tech Stack
* **Language:** Python 3.10+
* **Orchestration:** AWS Lambda, Amazon EventBridge
* **Machine Learning:** XGBoost, Graph Neural Networks (GNN), AWS SageMaker
* **Data Engineering:** Databricks (PySpark), Delta Lake, AWS S3
* **GenAI:** Amazon Bedrock (Claude 3.5 Sonnet), Agents for Bedrock

## ğŸ“‚ Project Structure
```text
â”œâ”€â”€ data/                  # Local datasets (gitignored)
â”œâ”€â”€ notebooks/             # Jupyter/Databricks notebooks for EDA
â”œâ”€â”€ src/
â”‚   â”œâ”€â”€ ingestion/         # Scripts for S3 uploads
â”‚   â”œâ”€â”€ training/          # SageMaker training scripts
â”‚   â””â”€â”€ lambda/            # AWS Lambda function logic
â”œâ”€â”€ infrastructure/        # IaC or setup scripts
â””â”€â”€ results/               # Prediction outputs
